Home / Intelligence / White Papers / How Five Oncology Treatment Paradigms Determine Strategic Choices for Commercial Success
New targeted oncology treatment regimens have changed cancer treatment. This white paper charts that development and analyzes five different approaches, providing an overview of how these paradigms determine strategic choices for commercial success. We observe that:
- The oncology treatment landscape has five distinct treatment paradigms.
- Competition, routes of administration, and market dynamics differ dramatically for each paradigm.
- The approach to commercialization needs to differ for each paradigm to increase uptake and ensure successful market penetration.
Related Intelligence
White Papers
What Is Keeping Community Oncology Providers Up at Night?
Community oncology practices are critical to the delivery of cancer care in the United States, treating about 80%, of patients. (~40% in community clinics and ~40% in community hospitals). Providing top-quality care in the community setting has unique challenges, including keeping pace with the accelerating innovation in cancer care (13 novel drugs and additional 67 […]
Read More
Blog
Priced Out: Generic Therapy Price Competition and Drug Shortages
Introduction In the summer of 2023, many oncologists and cancer patients faced an impossible choice. Amidst many challenging treatment decisions, they had to determine how to proceed without two mainstays among oncology therapeutics: cisplatin and carboplatin. While it can sometimes be expected that there may be delays for the newest and most innovative treatments to […]
Read More
Blog
Key Takeaways and Learnings from ASH 2023
Introduction The Trinity Life Sciences’ team recently attended the 65th ASH Annual Meeting and Exposition from December 9-12, 2023, in San Diego, California. The conference brought together physicians, scientists and industry experts to share and collaborate on advances in understanding and treating blood cancers and blood disorders. Below are a few of the key insights […]
Read More